These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6425418)

  • 1. [Interdependence between hormonal disorders, staging and degree of malignancy of prostatic gland cancer. 2].
    Szymanowski J; Baranowska B; Rozbicka G; Jeske W; Zgliczynski S
    J Urol (Paris); 1983; 89(9):663-8. PubMed ID: 6425418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interdependence between hormonal disorders, stage of development and degree of malignancy of prostatic cancer. 1].
    Szymanowski J; Baranowska B; Niewiadomska A; Wysocki M; Kobuszewska-Faryna M; Zgliczynski S
    J Urol (Paris); 1983; 89(8):597-600. PubMed ID: 6677708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigative clinical study on prostate cancer part VII: prolactin and the pituitary-testis-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.
    Porcaro AB; Ghimenton C; Petrozziello A; Migliorini F; Romano M; Sava T; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C; Comunale L
    Anticancer Res; 2011 Nov; 31(11):3913-20. PubMed ID: 22110219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in gonadotrophin and ovarian hormone levels during the estrous cycle of black-tailed deer (Odocoileus hemionus columbianus).
    McKeown BA; Sadleir RM
    Biochem Exp Biol; 1978; 14(3):215-20. PubMed ID: 571734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
    de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
    Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer.
    Kaku H; Saika T; Tsushima T; Ebara S; Senoh T; Yamato T; Nasu Y; Kumon H
    Prostate; 2006 Mar; 66(4):439-44. PubMed ID: 16329145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of radical prostatectomy on serum hormone levels.
    Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of prostatic cancer with slow-release formulation of luteinizing hormone releasing hormone (LH-RH) analog].
    Fuse H; Akimoto S; Akakura K; Shimazaki J; Murakami S
    Hinyokika Kiyo; 1988 Mar; 34(3):555-60. PubMed ID: 3133936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of spironolactone on the concentration of gonadotrophins and gonadal hormones in prostatic hypertrophy (author's transl)].
    Zgliczynski S; Baranowska B; Szymanowski J
    J Urol (Paris); 1981; 87(9):635-8. PubMed ID: 6174646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual variation of hormonal recovery after cessation of luteinizing hormone-releasing hormone agonist therapy in men receiving long-term medical castration therapy for prostate cancer.
    Kobayashi T; Nishizawa K; Mitsumori K
    Scand J Urol Nephrol; 2006; 40(3):198-203. PubMed ID: 16809259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some effects of orchiectomy, oestrogen treatment and radiation therapy in patients with prostatic carcinoma.
    Tomić R
    Scand J Urol Nephrol Suppl; 1983; 77():1-37. PubMed ID: 6426040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum prolactin, gonadotrophin and oestrogen levels in women receiving hormone replacement therapy.
    Lind T; Cameron EH; Hunter WM
    Br J Obstet Gynaecol; 1978 Feb; 85(2):138-41. PubMed ID: 626723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estrogens and progesterone on gonadotropin and prolactin release in a patient with androgen insensitivity.
    Nicoletti I; Filipponi P; Fedeli L; Santori PA; Santeusanio F
    Obstet Gynecol; 1981 Oct; 58(4):527-32. PubMed ID: 6792578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feedback effects of estradiol and progesterone upon gonadotropin and prolactin release.
    March CM; Marrs RP; Goebelsmann U; Mishell DR
    Obstet Gynecol; 1981 Jul; 58(1):10-6. PubMed ID: 6787487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The basal levels of serum prolactin (PRL), luteinizine hormone (LH), follicle stimulating hormone (FSH), testosterone, thyroxine (T4), and cortisol in patients with pituitary mass: detection and evaluation.
    Namking M; Pavasuthipaisit K; Lerthamtewe W; Bunyaratavej S; Himathongkam T
    J Med Assoc Thai; 1981 Feb; 64(2):76-85. PubMed ID: 6785372
    [No Abstract]   [Full Text] [Related]  

  • 18. Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer.
    Hsing AW; Comstock GW
    Cancer Epidemiol Biomarkers Prev; 1993; 2(1):27-32. PubMed ID: 8420607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine patterns associated with puberty in male and female cattle.
    Schams D; Schallenberger E; Gombe S; Karg H
    J Reprod Fertil Suppl; 1981; 30():103-10. PubMed ID: 6820050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary-testicular function of prostatic cancer patients during treatment with a gonadotropin-releasing hormone agonist analog. I. Circulating hormone levels.
    Huhtaniemi I; Nikula H; Rannikko S
    J Androl; 1987; 8(6):355-62. PubMed ID: 3123445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.